XIG: FHIR Resources

FHIR IG Statistics: FHIR Resources

Version: All | R2 | R2B | R3 | R4 | R4B | R5 | R6
Authority: All | hl7 | ihe | national
Realm: All | BNW | au | be | br | ca | ch | cl | cr | cz | de | dk | ee | eu | fi | fr | il | in | it | jp | kr | nl | no | nz | pl | se | sl | stt | tw | uk | us | uv | vn
View: All | Resource Profiles | Datatype Profiles | Extensions | Logical Models | CodeSystems | ValueSets | ConceptMaps

Resources - ValueSet

29,056 resources

By Version

R2: 0
R2B: 0
R3: 1,154
R4: 23,662
R4B: 244
R5: 3,968
R6: 28

By Authority

none: 8,611
hl7: 17,881
ihe: 218
national: 1,286
who: 1,060

By Realm

none: 5,874
au: 87
be: 108
br: 73
ca: 244
ch: 395
cl: 150
cr: 11
cz: 48
de: 680
dk: 475
ee: 66
eu: 349
fi: 4
fr: 810
il: 144
in: 48
it: 92
jp: 71
nl: 958
no: 6
nz: 17
pl: 23
se: 10
tw: 161
uk: 23
us: 13,139
uv: 4,925
vn: 23
other: 5

Start Prev Rows 600 - 800 Next

Package	Version	Identity	Name/Title	Status	Date	Realm	Auth
implementation.guide.nhdr	R4	ValueSet/EncounterTypeValueSet	EncounterTypeValueSet	draft
implementation.guide.nhdr	R4	ValueSet/IndigenousGroupValueSet	IndigenousGroupValueSet	draft
implementation.guide.nhdr	R4	ValueSet/MaritalStatusValueSet	MaritalStatusValueSet	draft
implementation.guide.nhdr	R4	ValueSet/OrganizationTypeValueSet	OrganizationTypeValueSet	draft
implementation.guide.nhdr	R4	ValueSet/PractitionerRoleValueSet	PractitionerRoleValueSet	draft
implementation.guide.nhdr	R4	ValueSet/SexValueSet	SexValueSet	draft
d4l-data4life.covid-19.r4	R4	ValueSet/pregnancy-de.ValueSet	Pregnant\|Not pregnant\|Unknown	active
de.abda.erezeptabgabedatenpkv	R4	ValueSet/DAV-PKV-VS-ERP-AbrechnungsTyp	DAV_PKV_VS_ERP_AbrechnungsTyp	active
de.abda.erezeptabgabedatenpkv	R4	ValueSet/DAV-PKV-VS-ERP-ZusatzattributSchluesselAutidemAustausch	DAV_PKV_VS_ERP_ZusatzattributSchluesselAutidemAustausch	active
de.abda.erezeptabgabedatenpkv	R4	ValueSet/DAV-PKV-VS-ERP-ZusatzdatenEinheitFaktorkennzeichen	DAV_PKV_VS_ERP_ZusatzdatenEinheitFaktorkennzeichen	active
de.thieme-compliance.anamnese	R4	ValueSet/UiWidgetsVS	UiWidgets	draft	2023-05
de.bbmri.fhir	R4	ValueSet/BiobankCapabilities	Biobank Capabilities	active	2020-05
de.bbmri.fhir	R4	ValueSet/CollectionType	Collection Type	active	2020-05
de.bbmri.fhir	R4	ValueSet/DataCategory	Data Category	active	2020-05
de.bbmri.fhir	R4	ValueSet/OtherSampleDiagnosis	other sample diagnosis	active	2020-05
de.bbmri.fhir	R4	ValueSet/QualityStandard	Quality Standard	active	2020-05
de.bbmri.fhir	R4	ValueSet/ResourceType	Resource Type	active	2020-05
de.bbmri.fhir	R4	ValueSet/SampleMaterialType	Sample Material Type	active	2020-05
de.bbmri.fhir	R4	ValueSet/StorageTemperature	Storage Temperature	active	2020-05
us.nlm.vsac	R4	ValueSet/1.2.91.13925.17760.1280649	Sneezing and Itching Grouping	active	2017-06	us
us.nlm.vsac	R4	ValueSet/1.2.91.13925.17760.15972546	Conditions Indicating Appropriate Sinonasal Imaging	active	2017-06	us
us.nlm.vsac	R4	ValueSet/1.2.91.13925.17760.16432390	Cerumen Impaction	active	2017-06	us
us.nlm.vsac	R4	ValueSet/1.2.91.13925.17760.16929355	Allergic Rhinitis Grouping	active	2017-06	us
us.nlm.vsac	R4	ValueSet/1.2.91.13925.17760.18316962	Severe Asthma	active	2017-06	us
us.nlm.vsac	R4	ValueSet/1.2.91.13925.17760.19613338	Immunoglobulin G Testing Grouping	active	2022-03	us
us.nlm.vsac	R4	ValueSet/1.2.91.13925.17760.23618223	Hearing Aids Grouping	active	2017-06	us
us.nlm.vsac	R4	ValueSet/1.2.91.13925.17760.24927846	Specific IgE testing	active	2017-06	us
us.nlm.vsac	R4	ValueSet/1.2.91.13925.17760.26050446	Ear Surgery Affecting the Tympanic Membrane	active	2017-06	us
us.nlm.vsac	R4	ValueSet/1.2.91.13925.17760.26878039	Specific IgE Testing	active	2022-03	us
us.nlm.vsac	R4	ValueSet/1.2.91.13925.17760.29996863	Immunoglobulin G testing	active	2017-06	us
us.nlm.vsac	R4	ValueSet/1.2.91.13925.17760.4352590	Benign Prostatic Hyperplasia	active	2017-08	us
us.nlm.vsac	R4	ValueSet/1.2.91.8867.26816.649902	Office or Outpatient Encounter	active	2017-07	us
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.33895.1.3.0.45	Comfort Measures	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.234.13.18.1.1.11.1.999.1	pain medication action plan	active	2015-08	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.234.999.3.2	All prescribable opioids used for pain control including Inactive Medications	active	2015-08	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.234.999.4.1	malignant neoplasms and cancer pain	active	2015-08	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.234.999.4.2	malignant neoplasms and cancer pain	active	2015-08	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.234.999.4.7	malignant neoplasms and cancer pain	active	2015-08	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.234.999.4.9	malignancy or cancer related pain	active	2015-08	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31172.1.1.999.150	Cerumen on Otoscopy	active	2017-02	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31172.1.1.999.151	Cerumen on Otoscopy	active	2017-02	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31172.1.1.999.152	Cerumen on Otoscopy	active	2017-02	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.12.1.999.172	Hearing Loss	active	2017-02	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.12.1.999.173	Hearing Loss	active	2017-02	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.12.1.999.174	Hearing Loss	active	2017-02	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.13.1.999.175	Tinnitus	active	2017-03	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.13.1.999.176	Tinnitus	active	2017-02	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.13.1.999.177	Tinnitus	active	2017-02	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.14.1.999.178	Ear Congestion	active	2017-02	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.15.1.999.179	Ear Pruritus	active	2017-02	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.16.1.999.180	Otalgia	active	2017-03	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.16.1.999.181	Otalgia	active	2017-02	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.16.1.999.182	Otalgia	active	2017-02	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31441.1.2.999.96	Initial Encounter with Otolaryngologist or undefined clinician	active	2017-03	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31471.1.11.1.999.204	Hearing Aids	active	2017-03	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31471.1.11.1.999.205	Hearing Aids	active	2017-03	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31471.1.11.1.999.206	Hearing Aids	active	2017-03	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31212.1.1.999.81	Cerumen Impaction	active	2017-03	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31212.1.1.999.82	Cerumen Impaction	active	2017-03	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31305.1.11.1.999.190	Radiotherapy	active	2017-03	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31305.1.11.2.999.191	Head and Neck Anatomic Locations	active	2017-03	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31305.1.11.2.999.192	Conditions Associated with Head and Neck Radiotherapy	active	2017-03	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31317.1.1.999.194	Ear Canal Stenosis	active	2017-03	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31317.1.1.999.195	Ear Canal Stenosis	active	2017-03	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31317.1.1.999.196	Ear Canal Stenosis	active	2017-03	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31329.1.1.999.197	Exostoses	active	2017-03	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31329.1.1.999.198	Exostoses	active	2017-03	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31329.1.1.999.199	Exostoses	active	2017-03	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31341.1.1.999.200	Non intact Tympanic Membrane	active	2017-03	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31341.1.1.999.201	Non Intact Tympanic Membrane	active	2017-03	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31341.1.1.999.202	Non Intact Tympanic Membrane	active	2017-03	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31481.1.11.1.999.246	Hearing Aids	active	2017-03	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31481.1.11.1.999.250	DO NOT USE	active	2017-03	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31481.1.12.1.999.251	Cerumenolytics	active	2017-03	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31481.1.12.1.999.252	Irrigation	active	2017-03	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31481.1.12.1.999.253	Irrigation	active	2017-03	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31593.1.12.1.999.288	Otoscopy performed on exam	active	2017-03	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31663.1.1.999.291	Otolaryngologist as a Clinician or Service	active	2017-03	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.265.8.31102.1.1.999.123	Cerumen Impaction	active	2017-02	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31104.1.1.999.275	Dermatologic Diseases of the Ear	active	2017-03	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31108.1.1.999.20	Keratoses Obturans	active	2017-02	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.11.1.999.221	Tympanoplasty	active	2017-03	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.11.1.999.222	Tympanoplasty	active	2017-03	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.12.1.999.223	Myringoplasty	active	2017-03	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.12.1.999.224	Myringoplasty	active	2017-03	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.13.1.999.225	Mastoidectomy	active	2017-03	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.13.1.999.229	Mastoidectomy	active	2017-03	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.14.1.999.227	Ear Surgery, Other	active	2017-03	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.14.1.999.228	Ear Surgery, Other	active	2018-01	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.268.12.31833.1.1.999.334	Sleep Apnea	active	2018-05	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.268.12.31833.1.1.999.336	Sleep Apnea	active	2018-05	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.34853.1.1.999.237	Allergic Rhinitis	active	2017-03	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.34853.1.1.999.238	Allergic Rhinitis	active	2017-03	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.34853.1.1.999.239	Allergic Rhinitis	active	2017-03	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.34951.1.11.1.999.263	Uncontrolled or severe asthma	active	2017-03	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.34951.1.11.1.999.264	Uncontrolled or severe asthma	active	2017-03	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.34951.1.11.1.999.265	Uncontrolled or severe asthma	active	2017-03	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.11.1.999.300	Rhinosinusitis	active	2017-03	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.11.1.999.301	Rhinosinusitis	active	2017-03	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.11.1.999.302	Rhinosinusitis	active	2017-03	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.12.1.999.303	Nasal Polyposis	active	2017-03	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.12.1.999.304	Nasal Polyposis	active	2017-03	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.12.1.999.305	Nasal Polyposis	active	2017-03	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.13.1.999.306	Suspected Nasal Neoplasm	active	2017-03	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.13.1.999.307	Suspected Nasal Neoplasm	active	2017-03	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.13.1.999.308	Suspected Nasal Neoplasm	active	2017-03	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.14.1.999.309	Other sinus conditions potentially requiring imaging	active	2017-08	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.14.1.999.310	Other sinus conditions potentially requiring imaging	active	2017-08	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35211.1.11.1.999.319	Intranasal Antihistamines	active	2017-06	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35211.1.12.1.999.320	Mast Cell Stabilizers	active	2017-06	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35211.1.13.1.999.321	Ophthalmic Antihistamines	active	2017-06	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35282.1.11.1.999.215	Sneezing as a finding	active	2017-03	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35282.1.11.1.999.216	Sneezing as a Clinical Condition	active	2017-03	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35282.1.12.1.999.217	Pruritus Unspecified or Other Location	active	2017-03	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35282.1.12.1.999.218	Pruritus Unspecified or Other Location	active	2017-03	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.34907.1.11.1.999.272	Specific IgE Testing for Allergies	active	2017-03	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.34907.1.12.1.999.273	Immunoglobulin G Testing	active	2017-03	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.34907.1.13.1.999.274	Total IgE Testing	active	2017-03	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.34920.1.1.999.290	Clinicians who perform allergy testing	active	2017-03	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.35043.1.1.999.279	Radiography of face, head or neck	active	2017-03	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.35221.1.11.1.999.315	Intranasal Corticosteroids	active	2017-03	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.35221.1.13.1.999.316	Eustachian Tube Dysfunction	active	2017-03	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.35221.1.13.1.999.317	Eustachian Tube Dysfunction	active	2017-03	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.35221.1.13.1.999.318	Eustachian Tube Dysfunction	active	2017-03	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.35292.1.1.999.287	Oral Second Generation and Less Sedating Antihistamines	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.35464.1.1.999.266	Leukotriene antagonist	active	2017-03	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.35607.1.11.1.999.267	Immunotherapy that is not Identified as Subcutaneous	active	2017-03	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.35607.1.14.1.999.268	Immunotherapy	active	2017-03	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.271.12.37641.1.1.999.653	Fidaxomicin	active	2019-04	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.37752.1.1.999.655	Clostridium difficile infection	active	2019-04	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.37752.1.1.999.656	Clostridium difficile infection	active	2019-04	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.37752.1.1.999.657	Clostridium difficile infection	active	2019-04	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38167.1.1.999.594	Complete Blood Count (with Diff)	active	2019-04	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38256.1.1.999.662	Metronidazole Systemic	active	2019-04	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38266.1.1.999.663	Vancomycin non injectable	active	2019-04	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38343.1.1.999.665	Creatinine	active	2019-04	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.11.1.999.722	Ileus due to infection	active	2019-04	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.11.1.999.723	Ileus due to infection	active	2019-04	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.11.1.999.724	Ileus due to infection	active	2019-04	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.12.1.999.725	Vomiting potentially due to CDI	active	2019-04	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.12.1.999.726	Vomiting potentially due to CDI	active	2019-04	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.12.1.999.727	Vomiting potentially due to CDI	active	2019-04	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.13.1.999.728	Toxic Megacolon in adults	active	2019-04	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.13.1.999.729	Toxic Megacolon in adults	active	2019-04	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.13.1.999.730	Toxic Megacolon in adults	active	2019-04	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.14.1.999.731	Abdominal Distension	active	2019-04	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.14.1.999.732	Abdominal Distension	active	2019-04	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38493.1.1.999.688	Septic Shock due to C. Diff	active	2019-04	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38493.1.1.999.689	Septic Shock due to C. Diff	active	2019-04	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38493.1.1.999.690	Septic Shock due to C. Diff	active	2019-04	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.271.15.37872.1.1.999.658	Antiperistaltic agents to avoid in C. diff	active	2019-04	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.271.15.37872.1.1.999.734	Systemic Antimicrobial Medications not used for CDI	active	2019-05	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.271.15.37937.1.11.1.999.659	Recurrent Clostridium difficile infection	active	2019-04	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.271.15.37937.1.13.2.999.660	History of CDI	active	2019-04	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.271.15.38112.1.1.999.661	Consult Infectious Disease	active	2019-04	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.271.15.38827.1.1.999.691	Abdominal Xrays for CDI	active	2019-04	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.271.15.38839.1.1.999.692	CT of abdomen with contrast for fulminant CDI	active	2019-04	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.271.15.38904.1.1.999.693	Surgical consult for CDI	active	2019-04	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.271.15.39406.1.1.999.694	Fecal microbiota transplantation	active	2019-04	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.271.4.37623.1.1.999.645	Hospitalist	active	2019-04	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.271.8.37627.1.1.999.697	Positive result indicator	active	2019-04	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.271.8.37627.1.1.999.698	Clostridium Difficile Test	active	2019-04	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.271.8.37631.1.11.1.999.646	Body Temperature	active	2019-04	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.271.8.37631.1.11.1.999.647	Body Temperature	active	2019-04	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.271.8.37631.1.12.1.999.648	Diarrhea Potentially due to CDI	active	2019-04	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.271.8.37631.1.12.1.999.649	Diarrhea Potentially due to CDI	active	2019-04	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.271.8.37631.1.12.1.999.650	Diarrhea Potentially due to CDI	active	2019-04	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.271.8.37631.1.13.1.999.651	Leukocyte count	active	2019-04	us	hl7
us.nlm.vsac	R4	ValueSet/1.3.6.1.4.1.6997.4.1.2.271.9.37637.1.1.999.652	Inpatient Setting	active	2019-04	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1010.4	Medication Clinical Drug	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1010.5	Medication Clinical Brand specific Drug	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1010.6	CVX Vaccines Administered Vaccine Set	active	2025-04	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1021.102	Unknown or did not answer	active	2021-10	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1021.103	Other or unknown or refused to answer	active	2021-11	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1021.12	Low Molecular Weight Heparin for VTE prophylaxis ingredient specific	active	2025-04	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1021.14	Published test VS	active	2023-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1021.24	Birth Sex	active	2024-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1021.46	Device Magnetic resonance (MR) Safety	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1021.47	Device Latex Safety	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1021.48	Implantable Device Status	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1021.56	Medical Reason Not Done SCT	active	2019-12	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.119	Phototherapy	active	2021-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.120	Phototherapy	active	2021-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.121	Phototherapy	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.122	Neonatal Jaundice	active	2023-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.123	Neonatal Jaundice	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.124	Neonatal Jaundice	active	2021-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.125	Maternal Drug Use	active	2021-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.126	Maternal Drug Use	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.127	Maternal Drug Use	active	2021-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.128	Fetal Conditions	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.129	Fetal Conditions	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.130	Fetal Conditions	active	2021-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.131	Congenital Malformations	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.132	Congenital Malformations	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.133	Congenital Malformations	active	2021-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.134	Social Indications	active	2024-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.135	Social Indications	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.136	Social Indications	active	2021-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.137	Neonatal Severe Birth Trauma	active	2021-06	us	hl7